Stroke, Intracranial Hemorrhage, and Bleeding following Dabigatran, Rivaroxaban, and Apixaban Use in Patients Aged 65 or Older: A Propensity Score Matched Analysis

    Basic Details
    Date Posted
    Monday, September 14, 2020
    Status
    Complete
    Medical Product
    apixaban
    dabigatran
    rivaroxaban
    Health Outcome(s)
    bleeding event
    intracranial hemorrhage
    stroke
    Description

    In this report we compared risk of stroke, intracranial hemorrhage, and bleeding outcomes associated with use of dabigatran, rivaroxaban, and apixaban in those aged 65 years or older in the Sentinel Distributed Database (SDD).

    The study period included data from October 19, 2010 to September 30, 2015. We distributed this request to 1 Data PartnerĀ on December 20, 2019.